INVENTING THE FUTURE OF MEDICINE
Xiaohu Gao, professor of bioengineering, and his lab have developed a new, cholesterol-based tag system to bring imaging and disease-treating proteins directly into a live cell, bypassing the cell’s defenses. They reported their finding June 19 in Science Advances.
Dr. Xiaohu Gao, professor of bioengineering, and Eva Corey, in UW Medicine’s Department of Urology, have developed a new way to deliver cancer-killing genetic material to prostate tumors that overcomes past hurdles. Their work appears today in Nature Biomedical Engineering.
The faculty promoted for the 2017-18 academic year demonstrate the department's strength in diverse areas of research, including disease diagnostics and therapeutics, regenerative medicine and protein engineering.
Xiaohu Gao and other UW researchers have discovered a simple way to increase the accuracy of commonly used diagnostic tests. By adding polydopamine — a material first isolated from shellfish — the team was able to increase the sensitivity of these common bioassays such as ELISA, micrarrays, FISH and immunohistochemistry imaging, by as many as 100 to 1,000 times.
To help lead the next major wave in medical diagnosis and treatment, the University of Washington is planning a molecular imaging center to bring individualized, precision medicine to patients. The UW held a symposium on Feb. 16, bringing leading researchers to campus to join in discussions shaping the new center.
Gao lab's "soak, drain, repeat" approach could reduce time waiting for an assay to produce results from hours and days to mere minutes.
UW Bioengineering associate professor Dr. Xiaohu Gao leads a team which has developed a new [...]
UW Bioengineering faculty Drs. David Castner and Xiaohu Gao were inducted as AIMBE Fellows at [...]
